Services

Platform 1 Biomolecules production

• U1-S01. Molecular cloning (On-site&Remote) OUTSTANDING
• U1-S02. Bioproduction of proteins (On-site&Remote) OUTSTANDING
• U1-S03: Proteins purification (On-site&Remote) OUTSTANDING
• U1-S04. Consultancy in protein production (On-site&Remote)
• U1-S05. Training courses in protein Production (On-site&Remote)
• U1-S06. Criopreservation (On-site&Remote)
• U2-S01. Scientific and technical support (Remote)
• U2-S02. Hapten synthesis (Remote) OUTSTANDING
• U2-S03. Preparation of Bioconjugates and Molecular Probes (Remote) OUTSTANDING
• U2-S04. Polyclonal Antibody Production (Remote) OUTSTANDING
• U2-S05. Monoclonal Antibody development (Remote) OUTSTANDING
• U2-S06. Hybridoma cell culture antibody production (Remote) OUTSTANDING
• U2-S07. Antibody purification (Remote) OUTSTANDING
• U2-S08. Inmunochemical methods development (Remote) OUTSTANDING
• U28-S07. Transmission Electron Microscopy (TEM) (Onsite&Remote)
• U29-S01. Synthesis of oligonucleotides and characterization (On-site & Remote). OUTSTANDING
• U29-S02. Modification of oligonucleotides. (Remote) OUTSTANDING
• U29-S03. Special nucleotides for oligonucleotide synthesis. (Remote) OUTSTANDING
• U3-S01. Synthesis of peptides and characterisation (On-site&Remote) OUTSTANDING
• U3-S02. Modification of the peptides (On-site&Remote) OUTSTANDING
• U3-S03. Special amino acids for peptide synthesis (Remote) OUTSTANDING
• U3-S04. Peptide libraries (Remote) OUTSTANDING

Platform 2 Biomaterials & nanomaterials production

• U6-S01. Use of High-pressure laboratory-scale plant with 50, 100 and 300 m reactors for the processing of biomaterials. Processing of cytotoxic compounds when required. (Remote) OUTSTANDING
• U6-S02. High-pressure phase analysis – solubility, emulsification (Remote) OUTSTANDING
• U6-S03. Thermal analysis of solid materials (Remote) OUTSTANDING
• U6-S04. Analysis of particle size, concentration and Z-potential of nanoparticles (On-site&Remote) OUTSTANDING
• U6-S05. Analysis of particle morphology (Remote) OUTSTANDING
• U6-S06. Fluorescence spectroscopic analysis (On-site&Remote)
• U6-S07. UV-Vis spectroscopic analysis (On-site&Remote)
• U6-S08. Visual observation (On-site&Remote)
• U6-S09. Centrifugation (On-site)
• U6-S10. Treatment of sample by ultrasound probe (On-site)
• U6-S11. Specific density of powders (On-site&Remote) OUTSTANDING
• U6-S12. Packed (tapped) density (On-site) OUTSTANDING
• U6-S13. Detection of labeled nanoparticles and exosomes by fluorescence mode (On-site&Remote) OUTSTANDING
• U6-S14. Quantitative studies of biomolecular interactions by calorimetric measurements (On-site) OUTSTANDING
• U7-S01. Training Courses in the Use of nanotechnology equipment (Onsite)
• U7-S03. Characterization by SEM (On-site&Remote) OUTSTANDING
• U7-S04. Lytography by e-beam (On-site&Remote) OUTSTANDING
• U7-S07. Photolithography and soft-lithography manufacturing processes (On-site&Remote) OUTSTANDING
• U7-S08. Fabrication of Chromium masks (Remote) OUTSTANDING
• U7-S09. Thin layer deposition (Remote) OUTSTANDING
• U7-S10. Advising and consulting in micro and nanofabrication (On-site&Remote)
• U7-S11. Contact angle (On-site&Remote) OUTSTANDING
• U7-S12. Contact Microarrayer (On-site) OUTSTANDING
• U8-S01. Design, fabrication and encapsulation of microelectrodes (based on gold or platinum) on different rigid (Si, SiC or Pyrex) or flexible polymeric substrates (On-site&Remote) OUTSTANDING
• U8-S02. Electrochemical and electrical characterization of the above mentioned microelectrodes (On-site&Remote) OUTSTANDING
• U8-S04. Graphene growth services (On-site&Remote) OUTSTANDING
• U8-S05 Deposition of thin films (Polyimide, Parylene) for the fabrication of flexible devices or encapsulation purposes (On-site&Remote) OUTSTANDING.
• U8-S06. Encapsulation or fabrication of 3D strcutures via 3D printing.
• U9-S01. Synthesis of NPs by laser induced-pyrolysis (Remote) OUTSTANDING
• U9-S02. Synthesis of Nps by wet methods and microfluidic technology (Remote) OUTSTANDING
• U9-S03. Characterization of nanoparticles (Remote) OUTSTANDING
• U9-S04. Drug delivery determination (Remote) OUTSTANDING
• U9-S05. Consultancy (Remote)
• U9-S6. Synthesis of NPs by microfluidics thecnologies (Remote) OUTSTANDING

• U10-S01. Design & Development of pharmaceutical forms (Remote) OUTSTANDING
• U10-S02. Design & Development of micro- & nanocapsules (Remote) OUTSTANDING
• U10-S03. Design & Development of solid lipid nanoparticules(SLN) (Remote) OUTSTANDING
• U10-S04. Design & Development of living cells containing microparticules (Remote) OUTSTANDING
• U10-S05. Biopharmaceutical evaluation of dosage forms (Remote) OUTSTANDING
• U10-S06. Setup and validation of analytical techniques (Remote) OUTSTANDING
• U10-S07. Pharmacokinetic pre-clinical studies (Remote) OUTSTANDING
• U10-S08. 3D bio-impression of scaffolding for regenerative medicine (On-site&Remote) OUTSTANDING
• U10-S09. Characterization and development of pulmonar formulations (On-site&Remote) OUTSTANDING

Platform 3 Preclinical validation Tissue, Biomaterials and Surfaces Characterization

• U12-S01. Characterization of colloidal dispersions by Dynamic and Static Light Scattering (DLS and SLS) and Light Diffraction (Remote) OUTSTANDING
• U12-S02. Characterization of nanomaterials by SAXS and porosimetry (Remote) OUTSTANDING
• U12-S03. Determination of the phase behavior of surfactant and polymers systems (Remote) OUTSTANDING
• U12-S04. Rheology, viscometry and densimetry (Remote) OUTSTANDING
• U12-S05. Surface and interfacial tensiometry (Remote) OUTSTANDING
• U12-S06. Contact angle and wettability (Remote) OUTSTANDING
• U12-S07. Evaluation of colloidal stability (Remote) OUTSTANDING
• U12-S08. Characterization of materials by high resolution optical microscopy with spectral analysis and scanning electron microscopy (Remote) OUTSTANDING
• U13-S01. MicrtoCT (OUT OF ORDER ) (Remote) OUTSTANDING
• U13-S03. Fatigue tests Instron 8874 (Remote) OUTSTANDING
• U13-S04. Dynamic mechanical analysis Instron 8874 (Remote) OUTSTANDING
• U13-S05. Uniaxial tensile test Instron MicroTester (Remote) OUTSTANDING
• U13-S06. Confined compression tests Instron MicroTester (Remote) OUTSTANDING
• U13-S07. Uniaxial tensile nano Bionix MTS (Onsite) OUTSTANDING
• U13-S08. ATOMIC FORCE MICROSCOPY IDENTATION TEST (On-site) OUTSTANDING
• U14-S01. Cell cultures (Onsite&Remote) OUTSTANDING
• U14-S02. Flow Cytometry (Onsite&Remote) OUTSTANDING
• U14-S03. Biomecanic evaluation of plantar pressure in large animal models (On-site) OUTSTANDING
• U14-S04. Cytokine quantification assays (On-site&Remote) OUTSTANDING
• U14-S05. Determination of cytokine concentration by flow cytometry (On-site&Remote) OUTSTANDING
• U14-S06. Lymphocyte proliferation assay (On-site&Remote) OUTSTANDING
• U15-S01. Magnetometry (Remote) OUTSTANDING
• U15-S02. Relaxometry (Remote) OUTSTANDING
• U16-S01. XPS (Remote) OUTSTANDING
• U16-S02. Ellipsometry (Remote) OUTSTANDING
• U16-S03. Calorimetry (Remote) OUTSTANDING
• U16-S04. Characterization by Tof-SIM (Remote) OUTSTANDING
• U16-S05. Characterization service by contact angle goniometry OUTSTANDING
• U16-S06. Topographic characterization service using optical profilometry OUTSTANDING
• U16-S07. Evaluation of the adhesion capacities and formation of biolayers of microorganisms on materials. Evaluation of bactericidal and/or bacteriostatic responses of materials. OUTSTANDING
• U17-S01. Confiocal Microscopy Service (Onsite) OUTSTANDING
• U18-S01. In vitro Nanotoxicology (Remote) OUTSTANDING
• U18-S02. In vivo Nanotoxicology, preclinical histopathology in animal models (Remote) OUTSTANDING
• U18-S03.  In vivo TOXICOLOGY (Onsite&Remote) OUTSTANDING
• U19-S01. Preclinical Studies (Onsite&Remote) OUTSTANDING
• U19-S03. Clinical Analysis Laboratory (On-site&Remote) OUTSTANDING
• U30-S01. Sample preparation for proteomic analysis
• U30-S02. Determination of molecular mass of peptides, proteins and other biomolecules
• U30-S03. Protein identification by mass spectrometry (MS) or MS/MS
• U30-S04. Quantitative shotgun proteomics by nLC-MS/MS
• U30-S05. Targeted proteomics analysis by MRM or PRM-MS
• U30-S06. Protein or peptide separation by liquid chromatography
• U30-S07. Protein separation by one- or two-dimensional gel electrophoresis
• U30-S08. Luminex or ELISA assay development and analysis
• U30-S09. Data analysis of proteomics experiments

Platform 4 Preclinical validation bioimaging

• U20-S01. Non-invasive optical imaging (bioluminescence and fluorescence) (Remote) OUTSTANDING
• U20-S010. Ultrasound imaging in vivo (Remote) OUTSTANDING
• U20-S012. Inmunihistochemistry on histological samples (Remote) OUTSTANDING
• U20-S013. Detection of microbial (bacterial and mycoplasma) contaminationpre
• U20-S014. Hemocompatibility: hemolysis, platelet aggregation, plasma coagulation times and complement activation
• U20-S015. Cytotoxicity: proliferation, LDH, apoptosis and ROS
• U20-S02. Animal models in oncology (Remote) OUTSTANDING
• U20-S03. In vivo Experimental consultancy (Remote) OUTSTANDING
• U20-S04. In vivo Efficay Assays of drugs, nanomedicines, biomaterials and others (Remote) OUTSTANDING
• U20-S05. In vivo Toxicology (Onsite&Remote) OUTSTANDING
• U20-S06. In vivo ADME and biodistribution assays (Remote) OUTSTANDING
• U20-S07. In vivo PK/PD assays (Remote) OUTSTANDING
• U20-S08. Immunotoxicity assays (On-site&Remote) OUTSTANDING
• U20-S09. X-ray imaging in vitro and in vivo (Remote) OUTSTANDING
• U20-S11. Histological porcessing, section and staining (Remote) OUTSTANDING
• U21-S01. In vivo Efficay Assays of drugs, nanomedicines, biomaterials and others (Remote) OUTSTANDING
• U22-S01. Animal Housing (Remote) OUTSTANDING
• U22-S02. In vivo experimental design/consultancy for preclinal studies (On-site&Remote)
• U22-S03. In vivo toxicology in rodent and non-rodent species (On-site)
• U22-S04. In vivo biocompatibility studies of medical devices in rodent and non-rodent species (On-site)
• U22-S05. In vivo PK/PD assays in rodent and non-rodent species (On-site)
• U22-S06. In vivo safety and effcacy studies of nanomaterials, biomaterials and new drugs in rodent and non-rodent species (On-site) OUTSTANDING
• U22-S07. Development of animal models of disease in large animals (On-site) OUTSTANDING
• U22-S08. Dosing of test substances and non clinical specimen drawing in rodent and non-rodent species (On-site) OUTSTANDING
• U23-S01. In vitro fertilisation studies and embryo culture media viability (Onsite&Remote) OUTSTANDING
• U23-S02. Embryo culture media viability studies (Onsite&Remote) OUTSTANDING
• U23-S03. Micromanipulation and microinjection (Onsite&Remote) OUTSTANDING
• U23-S04. Sperm, Oocyte and embryo cryopreservation (On-site&Remote) OUTSTANDING
• U23-S05. In vitro Maduration (On-site&Remote) OUTSTANDING
• U23-S06. IMSI system (On-site&Remote) OUTSTANDING
• U23-S07. Laser System and Biopsed of blastomeres (On-site&Remote) OUTSTANDING
• U23-S08. Oosight system (On-site&Remote) OUTSTANDING
• U23-S09. Quality control for Human Assisted Reproduction clinics (On-site&Remote) OUTSTANDING
• U24-S01 Evaluation of therapies for cardiovascular disease
• U24-S02. Medical Imaging for Minimally Invasive Surgery (Onsite&Remote) OUTSTANDING
• U25-S01. NMR spectrometer 250MHZ robot/250MHZ auto/360MHZ/400MHZ (Onsite&Remote) OUTSTANDING
• U25-S02. NMR spectrometer 500MHz/600MHz (Onsite&Remote) OUTSTANDING
• U25-S03. NMR spectrometer 400 MHz with HRMAS/CPMAS probes (Onsite&Remote) OUTSTANDING
• U25-S04. 500 MHz spectrometer HPLC-NMR(Onsite&Remote) OUTSTANDING
• U25-S05. Preclinical horizontal spectrometer Biospec 7T (Onsite&Remote) OUTSTANDING
• U25-S06. Dynamic nuclear polarizer HyperSense® (Onsite&Remote) OUTSTANDING
• U25-S07. Focused Microwave Fixation system (Onsite&Remote) OUTSTANDING
• U25-S08. NMR consultancy for processing and interpreting data (Onsite&Remote)
• U25-S09. Access to specific software and database (Remote) OUTSTANDING
• U26-S01. Acquisition of mono and bidimensional spectra (On-site&Remote) OUTSTANDING
• U26-S02. NMR experiments in solid state (Remote) OUTSTANDING
• U26-S03. Metabolomic Studies (Remote) OUTSTANDING
• U26-S04. In vivo NMR of small animals(zebrafish,Drosophila (Remote) OUTSTANDING
• U26-S05. Training Advice and assistance (On-site&Remote)
• U26-S06. Biomedical and metabolomic imaging (On-site)
• U28-S01. Magnetic Resonance Imaging (MRI) (Onsite&Remote) OUTSTANDING
• U28-S010. Scanning Electron Microscopy (SEM) (Onsite&Remote)
• U28-S011. Environmental SEM (ESEM) (Onsite&Remote) OUTSTANDING
• U28-S012. Cryo-ultramicrotomy (Onsite&Remote) OUTSTANDING
• U28-S013. High-pressure freezing (Onsite&Remote) OUTSTANDING
• U28-S014. Freeze substitution (Onsite&Remote) OUTSTANDING
• U28-S015. Sample vitrification (Onsite&Remote) OUTSTANDING
• U28-S016. Confocal Microscopy (Onsite&Remote) OUTSTANDING
• U28-S017. Multiphoton Microscopy (Onsite&Remote) OUTSTANDING
• U28-S018. Super-resolution Microscopy (Onsite&Remote) OUTSTANDING
• U28-S019. Fluorescence microscopy (Onsite&Remote)
• U28-S02. Fluorescent and Bioluminescent Optical Imaging (Onsite&Remote) OUTSTANDING
• U28-S020. High Content Screening (Onsite&Remote) OUTSTANDING
• U28-S021. Flow Citometry/Cell Sorter (Onsite&Remote)
• U28-S03. Computed Tomography (CT) (Onsite&Remote)
• U28-S04. High Resolution Liquid NMR (Onsite&Remote) OUTSTANDING
• U28-S05. High Resolution Magic Angle Spinning (HR-MAS) NMR (Onsite&Remote)
• U28-S06. Time Domain NMR (TD-NMR) (Onsite&Remote)
• U28-S08. Cryo-TEM (Onsite&Remote) OUTSTANDING

Platform 5 High perfomance computing

• U27-S01. Remote access to HPC (On-site&Remote)
• U27-S02. Software installation on demand (Onsite&Remote) OUTSTANDING
• U27-S03. Biomedical signals processing, especially in cardiology (Onsite&Remote) OUTSTANDING
• U27-S04. Modeling of the functional behaviour of tissues and organs (Onsite&Remote) OUTSTANDING
• U27-S05. Massive parallel processing (Onsite&Remote)
• U27-S06. Mass storage (Onsite&Remote)